Showing 1711-1720 of 2123 results for "".
- Update on Neurologic Post-Acute Sequelae of SARS-CoV-2 Infectionhttps://practicalneurology.com/news/update-on-neurologic-post-acute-sequelae-of-sars-cov-2-infection/2470167/The concept of “original antigenic sin” may play an i
- FDA Approves Neonatal Fc Receptor Blocker Treatment for Individuals with Generalized Myasthenia Gravishttps://practicalneurology.com/news/fda-approves-neonatal-fc-receptor-blocker-treatment-for-individuals-with-generalized-myasthenia-gravis/2474395/The Food and Drug Administration (FDA) has approved IMAAVY (nipocalimab; Johnson & Johnson, New Brunswick, NJ) for the treatment of individuals aged >12 years with generalized myasthenia gravis (gMG) who are anti-acetylcholine receptor (AChR) or anti-muscle-specific tyrosine kinase (MuSK)
- Physician Visits Increased Up to 15 Years Before MS Symptom Onsethttps://practicalneurology.com/news/physician-visits-increased-up-to-15-years-before-ms-symptom-onset/2476101/Results from a large, matched cohort study published in JAMA Network Open reveal that health care use begins to rise 14 to 15 years before the onset of the first recognized symptoms of multiple sclerosis (MS). The findings suggest a longer prodromal phase than previously understood, with
- Treatment of Focal Epilepsy with Cenobamate Associated with Lower Inpatient Days and ER Visits Compared with 7 Leading Anti-Seizure Medicationshttps://practicalneurology.com/news/treatment-of-focal-epilepsy-with-cenobamate-associated-with-lower-inpatient-days-and-er-visits-compared-with-7-leading-anti-seizure-medications/2470448/The addition of cenobamate to the treatment regimens of people with focal epilepsy was associated with lower rates of inpatient days and emergency room (ER) visits compared with the addition of 7 other leading anti-seizure medications (ASMs). This finding, which was presented at the American Acad
- Prescription Digital Therapeutic Reduced Insomnia Severity and Decreased Emergency Department Visitshttps://practicalneurology.com/news/prescription-digital-therapeutic-reduced-insomnia-severity-and-decreased-emergency-department-visits/2470000/In analysis of real-world data, prescription digital therapeutic (PDT) (Somryst; Pear Therapeutics, Boston, MA) showed clinically meaningful reductions in insomnia severity index (ISI) score after 9 weeks of. People who used the PDT also had reductions in health-related services and costs in the
- Study Suggests Key Topics to Discuss in Initial Alzheimer’s Diagnostic Visithttps://practicalneurology.com/news/study-suggests-key-topics-to-discuss-in-initial-alzheimers-diagnostic-visit/2468963/Research has identified 17 topics in 4 categories that people with Alzheimer’s disease (AD), their caregivers, and health care professionals feel are important to discuss, as well as the timing for the discussion topics (Table).
- Fosgonimeton Well Tolerated With Possible Benefits for Alzheimer Disease in the Absence of Cholinergic Treatmenthttps://practicalneurology.com/news/fosgonimeton-well-tolerated-with-possible-benefits-for-alzheimer-disease-in-the-absence-of-cholinergic-treatment/2469991/In the phase 2 ACT-AD trial (NCT04491006), fosgonimeton (Athira Pharma, Bothell, WA) was well-tolerated, and no serious adverse events (AEs ) occurred. Mild-to-moderate AEs occurred in 89% (24/27) and 100% (26/26), respectively,
- AAN Issues Guideline on Vaccines for People With Multiple Sclerosishttps://practicalneurology.com/news/aan-issues-guideline-on-vaccines-for-people-with-multiple-sclerosis/2469002/In a guideline published in the current online issue of Neurology, the American Academy of Neurology (AAN) recommends that people with multiple sclerosis (MS) receive recommended vaccinations, including y
- Cases of Dementia Projected to Increase Worldwidehttps://practicalneurology.com/news/cases-of-dementia-projected-to-increase-worldwide/2469646/Data presented at the Alzheimer's Association International Congress July 26-30, 2021 show that all types of dementia have been on the rise in recent years and are predicted to increase further. Rates of early-onset dementia are also increasing, and in the US, mortality from Alzheimer diseae
- Healthy Midlife Choices May Reduce Risk of Stroke in Womenhttps://practicalneurology.com/news/healthy-midlife-choices-may-reduce-risk-of-stroke-in-women/2469224/A study published in Stroke shows better eating habits, maintaining a healthy weight, exercising, and not smoking beginning at midlife may still significantly reduce stroke risk. During the 26-year follow-up, researchers found: • smoking cessation, da